The effect of Phyllanthus niruri and Catharanthus roseus on Macrophage Polarization in Breast Cancer Mice Model
The Effect of P. niruri and C. roseus in Breast Cancer Mice Model
DOI:
https://doi.org/10.11594/jtls.14.01.03Keywords:
Cancer, Catharanthus roseus, IFN-γ, IL-10, Phyllanthus niruriAbstract
Cancer death cases have increased yearly, and there are estimated to be 21.6 million cancer cases in 2030. Studies of herbal compounds for cancer treatment alternatives are essential because cancer treatment is relatively expensive and has adverse effects. Phyllanthus niruri (Pn) and Catharanthus roseus (Cr) are plants that are known as herbal medicines. Combining the two plants is expected to prevent and enhance the immune system in breast cancer cases. This study aims to analyze the anti-cancer and immunomodulatory effects of P. niruri and C. roseus extract (PCE) in modulating macrophage polarization in breast cancer mice. Experimental animals are divided into six groups and there is healthy control (normal mice), cancer (DMBA-induced mice), cancer mice with cisplatin administration, cancer mice with PCE administration with three different doses, including dose 1 (500 mg/kg Pn + 15 mg/kg Cr), dose 2 (1000 mg/kg Pn + 75 mg/kg Cr), and dose 3 (2000 mg/kg Pn + 375 mg/kg Cr). The mice were injected with DMBA once a week for six weeks to induce cancer in mice. The breast cancer mice model was administered with PCE orally for 14 days. The expression of CD11b+IL-10+ and CD11b+IFN-γ+ demonstrated macrophage polarization. The results showed that breast cancer induction using DMBA increased the level of IL-10 and decreased the level of IFN-γ significantly compared to the normal group (p < 0.05). In specific doses, administration of PCE could reduce IL-10 levels and increase the level of IFN-γ significantly (p < 0.05). PCE can modulate the polarization of macrophages by suppressing the M2-like macrophage and increasing the M1-like macrophage. The ability of PCE to modulate macrophage polarization indicates that the combination of P. niruri and C. roseus has activity as an anti-cancer.
References
Sung H, Ferlay J, Siegel RL et al. (2021) Global Can-cer Statistics 2020: GLOBOCAN Estimates of Inci-dence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 71 (3): 209–249. doi: 10.3322/caac.21660.
Gelband H, Jha P, Sankaranarayanan R et al. (2015) Cancer. Washington, DC, The World Bank.
Boutilier AJ, Elsawa SF (2021) Macrophage Polariza-tion States in the Tumor Microenvironment. Interna-tional Journal of Molecular Sciences 22 (13): 6995. doi: 10.3390/ijms22136995.
Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496 (7446): 445–455. doi: 10.1038/nature12034.
Jorgovanovic D, Song M, Wang L, Zhang Y (2020) Roles of IFN-γ in tumor progression and regression: a review. Biomarker Research 8 (1): 49. doi: 10.1186/s40364-020-00228-x.
Müller E, Christopoulos PF, Halder S et al. (2017) Toll-Like Receptor Ligands and Interferon-γ Syner-gize for Induction of Antitumor M1 Macrophages. Frontiers in Immunology 8 (1383): 1–16. doi: 10.3389/fimmu.2017.01383.
Zhou J, Tang Z, Gao S et al. (2020) Tumor-Associated Macrophages: Recent Insights and Therapies. Fron-tiers in Oncology 10 (188): 1–13. doi: 10.3389/fonc.2020.00188.
Sheikhpour E, Noorbakhsh P, Foroughi E et al. (2018) A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative. Reports of Biochemistry & Molecular Biology 7 (1): 30–37.
Bagalkotkar G, Sagineedu SR, Saad MS, Stanslas J (2010) Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review. Journal of Pharmacy and Pharmacology 58 (12): 1559–1570. doi: 10.1211/jpp.58.12.0001.
Kaur N, Kaur B, Sirhindi G (2017) Phytochem-istry and Pharmacology of Phyllanthus niruri L.: A Review: Phyllanthus niruri L. Phytotherapy Research 31 (7): 980–1004. doi: 10.1002/ptr.5825.
Kumar S, Singh B, Singh R (2022) Catharanthus roseus (L.) G. Don: A review of its eth-nobotany, phytochemistry, ethnopharmacology and toxicities. Journal of Ethnopharmacology 284 (2022): 1–44. doi: 10.1016/j.jep.2021.114647.
Aslam J, Khan SH, Siddiqui ZH et al. (2010) Catharanthus roseus (L.) G. Don. An Important Drug: It’s Applications and Production. Pharmacie Global 01 (4): 1–16.
Asare G, Addo P, Bugyei K et al. (2011) Acute toxicity studies of aqueous leaf extract of Phyl-lanthus niruri. Interdisciplinary Toxicology 4 (4): 206–210. doi: 10.2478/v10102-011-0031-9.
Bhattacharjee HK, Bansal VK, Nepal B et al. (2016) Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis? Indian Journal of Surgical Oncology 7 (3): 320–325. doi: 10.1007/s13193-016-0512-6.
Gao J, Mitchell LA, Lauer FT, Burchiel SW (2008) p53 and ATM/ATR Regulate 7,12-Dimethylbenz[ a ]anthracene-Induced Immunosup-pression. Molecular Pharmacology 73 (1): 137–146. doi: 10.1124/mol.107.039230.
Youssef SSM, Ibrahim NK, El-Sonbaty SM, El-Din Ezz MK (2022) Rutin Suppresses DMBA Carcin-ogenesis in the Breast Through Modulating IL-6/NF-κB, SRC1/HSP90 and ER-α. Natural Product Com-munications 17 (9): 1–11. doi: 10.1177/1934578X221118213.
Teng F, Tian W-Y, Wang Y-M et al. (2016) Cancer-associated fibroblasts promote the progres-sion of endometrial cancer via the SDF-1/CXCR4 ax-is. Journal of Hematology & Oncology 9 (1): 8. doi: 10.1186/s13045-015-0231-4.
Noy R, Pollard JW (2014) Tumor-Associated Macrophages: From Mechanisms to Therapy. Im-munity 41 (1): 49–61. doi: 10.1016/j.immuni.2014.06.010.
Yang L, Zhang Y (2017) Tumor-associated macrophages: from basic research to clinical applica-tion. Journal of Hematology & Oncology 10 (1): 58. doi: 10.1186/s13045-017-0430-2.
Castro F, Cardoso AP, Gonçalves RM et al. (2018) Interferon-Gamma at the Crossroads of Tu-mor Immune Surveillance or Evasion. Frontiers in Immunology 9 (847): 1–19. doi: 10.3389/fimmu.2018.00847.
Mandai M, Hamanishi J, Abiko K et al. (2016) Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity. Clinical Cancer Research 22 (10): 2329–2334. doi: 10.1158/1078-0432.CCR-16-0224.
Teresa Gonzalez-Garza M, Elva Cruz-Vega D, Maldonado-Bernal C (2021) IL10 as Cancer Bi-omarker. Transl Res Cancer. doi: 10.5772/intechopen.90806
Kumar P, Barua CC, Sulakhiya K, Sharma RK (2017) Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activi-ty in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy. Front Pharmacol 8 (132): 1–12. doi: 10.3389/fphar.2017.00132
Aldossary SA (2019) Review on Pharmacology of Cisplatin: Clinical Use, Toxicity and Mechanism of Resistance of Cisplatin. Biomedical and Pharmacolo-gy Journal 12 (1): 07–15. doi: 10.13005/bpj/1608.
Ramadhani A, Ahkam A, Suharto A et al. (2021) Suppression of hypoxia and inflammatory pathways by Phyllanthus niruri extract inhibits an-giogenesis in DMBA-induced breast cancer mice. Re-search in Pharmaceutical Sciences 16 (2): 217. doi: 10.4103/1735-5362.310528.
Jantan I, Haque MdA, Ilangkovan M, Arshad L (2019) An Insight Into the Modulatory Effects and Mechanisms of Action of Phyllanthus Species and Their Bioactive Metabolites on the Immune System. Frontiers in Pharmacology 10 (878): 1–19. doi: 10.3389/fphar.2019.00878.
Rauf A, Imran M, Khan IA et al. (2018) Anti-cancer potential of quercetin: A comprehensive re-view: Quercetin as an anticancer agent. Phytothera-py Research 32 (11): 2109–2130. doi: 10.1002/ptr.6155.
Widowati W, Mozef T, Risdian C et al. (2010) Apoptosis and Antioxidant Activities of Catharanthus rosues [L] G.Don Extract on Breast Cancer Cell Line. Indonesian Journal of Cancer Chemoprevention 1 (2): 99. doi: 10.14499/indonesianjcanchemoprev1iss2pp99-107.
Arora R (2010) Herbal Medicine: A Cancer Chemopreventive and Therapeutic Perspective. doi: 10.5005/jp/books/11166.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Tropical Life Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The work has not been published before (except in the form of an abstract or part of a published lecture or thesis) and it is not under consideration for publication elsewhere. When the manuscript is accepted for publication in this journal, the authors agree to automatic transfer of the copyright to the publisher.
Journal of Tropical Life Science is licensed under Creative Commons Attribution-NonCommercial 4.0 International License
_.png){kind=logo}
